Management Team
Dr. Chia-Nan Chen
Chairman of the Board / President
In 2013, Dr. Chen was one of the founders of GNTbm and served as a board member and the President. Since 2016, he has served as the Chairman of the Board/ President. Dr. Chen studied pharmacy, passed the national examination and is a pharmacist. He conducted further study and focused on research in the fields of chemistry, biochemistry, and molecular biology. He received his Ph.D. in Biochemistry and Molecular Biology in 2004 from the College of Medicine at National Taiwan University and then joined the National Health Research Institutes (NHRI, Taiwan) as a postdoctoral fellow. After his postdoctoral training, Dr. Chen moved into industry, where he served as the Vice President of Research and Development for NatureWise Biotech and Medicals Corporation, which is mainly engaged in the development of new drugs, and then as the Vice President and President in GNT Inc. Now, Dr. Chen is the Chairman of the Board and the President of GNTbm. Dr. Chen is devoted to the development of epigenetic modulators, tumor microenvironment regulators, epigenetic immunoactivators, and immunoregulatory multi-tyrosine kinase inhibitors in cancer immunotherapy field. He has applied for, and been awarded, invention patents overseas for more than 15 projects, and has published more than 20 scientific articles in international journals. Dr. Chen’s biggest passion is to develop new drugs to satisfy the unmet needs of advanced cancer patients.
Dr. Ye-Su Chao
Vice President
Dr. Ye-Su Chao has served as the Vice President of GNTbm since 2014; she assists mainly in business operations, business development, and R&D progress. Dr. Chao received her Ph.D. in Molecular Biology from the University of Southern California in 1992, specializing in gene expression and regulation. After graduation, Dr. Chao continued her postdoctoral research at the University of California, Berkeley, and at the University of California, San Francisco, from 1992 to 1997, focusing on gene regulation in plants and the HIV virus. From 1998 to 1999, as a research scientist, she studied gene regulation in breast cancer at the University of California, San Francisco. From 2000 to 2002, she was a researcher at the Industrial Technology Research Institute, and from 2002 to 2014, she worked for the Development Center for Biotechnology, once serving as the Director of the Technology Transfer Department and a Program Director, committed to the promotion of the development of biotechnology and pharmaceutical industries.
Dr. Jia-Shiong Chen
Director of the R&D Center
Since 2016, Dr. Jia-Shiong Chen has been the manager of R&D Center at GNTbm and is responsible mainly for R&D. Dr. Chen graduated from the Department of Pharmacology at National Yang-Ming University, where he specialized in research into the use of small molecule drugs in the treatment and prevention of cardiovascular diseases. He is experienced in anti-atherosclerosis research and vascular stem cell culture and its application in cell therapy, especially in animal models. Dr. Chen received his Ph.D. in 2011 and subsequently worked for the Institute of Clinical Medicine at the National Yang-Ming University as a postdoctoral fellow for four years, mainly focusing on the development of animal models of obesity, metabolic diseases, and cardiovascular diseases. Dr. Chen has published more than 31 scientific articles in international journals.
Pei-Ching Hsu
Director of Administration Department
Mrs. Hsu obtained a master's degree of of Health Care Administration, College of Management at Taipei Medical University. She has many years of experience in the management and operational performance. Since 2014, she has served as the manager of the Administration Department at GNTbm, where her main responsibilities include establishing management systems and monitoring budget execution, as well as overseeing procurement, human resources management, and information-related tasks.
Chen-Chia Tang
Financial and Accounting Manager
Mr. Tang obtained a master's degree of accounting in Soochow University and joined GNTbm in December 2024, responsible for the financial and accounting affairs. He has many years of industry experience. Before joining GNTbm, Mr. Tang worked in the big four international accounting firms and publicly listed companies, responsible for audit, accounting and finance. He also worked in a biotech company in charge of the enterprise resource planning system (ERP) and financial affairs.
Dr. Chiung-Ho Liao
Regulatory Affairs Manager
Dr. Chiung-Ho Liao currently serves as the Regulatory Affairs Manager at GNTbm. After graduating from the Institute of Biochemistry and Molecular Biology, Medical School, National Taiwan University, Dr. Liao conducted postdoctoral research at the National Health Research Institutes. She then entered the new drug industry, working in drug production management and IND submission. Subsequently, she served at Taiwan Food and Drug Administration, Ministry of Health and Welfare, starting in 2010, handling drug inspection and registration, changes, and extension cases, and was responsible for the review of technical document such as APIs and drug product. Driven by her continued interest in the full spectrum of new drug development and commercialization, she left Taiwan Food and Drug Administration in 2024 to join GNTbm, where she now focuses on pharmaceutical regulatory affairs and collaborates on the development of novel cancer therapies.
